Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pinna

Showing results (491-500 of 595) with videos related to

Pageof 60
Sort By:
Transplantation|May 8, 1999
Recurrence of desmoid tumor in a multivisceral transplant patient with Gardner's syndromeE P Misiakos, A Pinna, T Kato, et al.
Cancer Letters|November 5, 2011
Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cellsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
Archiv Der Pharmazie|April 28, 2000
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitorsG A Pinna, M M Curzu, G Murineddu, et al.
Cellular and Molecular Life Sciences : CMLS|July 2, 2011
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1AStefania Sarno, Marco Mazzorana, Ryan Traynor, et al.
Biochemistry|July 19, 2008
The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptideGiorgia Poletto, Jordi Vilardell, Oriano Marin, et al.
European Journal of Biochemistry|March 1, 1996
A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and LynP Agostinis, A Donella-Deana, C Van Hoof, et al.
Journal of Medicinal Chemistry|November 30, 2004
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazoleMario A Pagano, Mariola Andrzejewska, Maria Ruzzene, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 1998
RetractionsE Buchdunger, U Trinks, H Mett, et al.
European Journal of Biochemistry|June 1, 1997
Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and LynM Ruzzene, Z Songyang, O Marin, et al.
Biopolymers|October 1, 2003
Conformational constraints of tyrosine in protein tyrosine kinase substrates: Information about preferred bioactive side-chain orientationPaolo Ruzza, Andrea Calderan, Arianna Donella-Deana, et al.
Pageof 60

Showing results (491-500 of 595) with videos related to

Sort By:
Pageof 60
Transplantation|May 8, 1999
Recurrence of desmoid tumor in a multivisceral transplant patient with Gardner's syndromeE P Misiakos, A Pinna, T Kato, et al.
Cancer Letters|November 5, 2011
Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cellsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
Archiv Der Pharmazie|April 28, 2000
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitorsG A Pinna, M M Curzu, G Murineddu, et al.
Cellular and Molecular Life Sciences : CMLS|July 2, 2011
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1AStefania Sarno, Marco Mazzorana, Ryan Traynor, et al.
Biochemistry|July 19, 2008
The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptideGiorgia Poletto, Jordi Vilardell, Oriano Marin, et al.
European Journal of Biochemistry|March 1, 1996
A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and LynP Agostinis, A Donella-Deana, C Van Hoof, et al.
Journal of Medicinal Chemistry|November 30, 2004
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazoleMario A Pagano, Mariola Andrzejewska, Maria Ruzzene, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 1998
RetractionsE Buchdunger, U Trinks, H Mett, et al.
European Journal of Biochemistry|June 1, 1997
Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and LynM Ruzzene, Z Songyang, O Marin, et al.
Biopolymers|October 1, 2003
Conformational constraints of tyrosine in protein tyrosine kinase substrates: Information about preferred bioactive side-chain orientationPaolo Ruzza, Andrea Calderan, Arianna Donella-Deana, et al.
Pageof 60